Patriot Financial Group Insurance Agency, LLC Gilead Sciences, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$57.72 - $65.01 $2,077 - $2,340	36 Added 1.57%	2,324 $144,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $7,761 - $9,725	-134 Reduced 5.53%	2,288 $136,000
Q4 2021 Jan 10, 2022	BUY	$64.88 - $73.64 $7,720 - $8,763	119 Added 5.17%	2,422 $176,000
Q3 2021 Nov 24, 2021	BUY	$67.69 - $73.03 $17,599 - $18,987	260 Added 12.73%	2,303 $161,000
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $59,661 - $65,188	-940 Reduced 31.51%	2,043 $141,000
Q1 2021 Apr 29, 2021	SELL	$60.0 - $68.46 $8,640 - $9,858	-144 Reduced 4.61%	2,983 $193,000
Q4 2020 Jan 15, 2021	SELL	$56.65 - $64.55 $264,725 - $301,642	-4,673 Reduced 59.91%	3,127 $182,000
Q3 2020 Oct 21, 2020	SELL	$62.1 - $78.08 $293,608 - $369,162	-4,728 Reduced 37.74%	7,800 $493,000
Q2 2020 Jul 10, 2020	BUY	$72.34 - $84.0 $727,451 - $844,704	10,056 Added 406.8%	12,528 $964,000
Q1 2020 Apr 15, 2020	BUY	$62.63 - $80.22 $95,072 - $121,773	1,518 Added 159.12%	2,472 $185,000
Q4 2019 Jan 22, 2020	SELL	$61.62 - $67.78 $111,162 - $122,275	-1,804 Reduced 65.41%	954 $62,000
Q3 2019 Oct 25, 2019	SELL	$62.51 - $69.0 $61,634 - $68,034	-986 Reduced 26.34%	2,758 $175,000
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $9,033 - $10,129	146 Added 4.06%	3,744 $258,000
Q1 2019 Apr 29, 2019	BUY	$62.53 - $70.05 $12,443 - $13,939	199 Added 5.85%	3,598 $234,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $40,561 - $52,930	-670 Reduced 16.47%	3,399 $213,000
Q3 2018 Oct 30, 2018	BUY	$71.28 - $78.92 $251,190 - $278,114	3,524 Added 646.61%	4,069 $314,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $99,785 - $116,395	-1,538 Reduced 73.84%	545 $39,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $4,880 - $5,949	-67 Reduced 3.12%	2,083 $152,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $924 - $1,085	13 Added 0.61%	2,150 $159,000
Q3 2017 Oct 26, 2017	SELL	$72.11 - $85.47 $22,137 - $26,239	-307 Reduced 12.56%	2,137 $175,000
Q2 2017 Aug 08, 2017	BUY	N/A	2,444	2,444 $169,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account